Garnett and colleagues identified an unexpected highly significant association between the EWS-FLI1 translocation and sensitivity to the PARP inhibitor olaparib ( Garnett et al., 2012 ).
← all excerpts
Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells.
1
—
—